Tananbaum James B. - Insider Non-Derivative Transactions at Kinnate Biopharma Inc. (KNTE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 3, 2024, Tananbaum James B.'s relationship to Kinnate Biopharma Inc. (KNTE) is Director,TenPercentOwner, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KNTE insiders.
Data Source: SEC.
Tananbaum James B. - Insider Non-Derivative Transactions of KNTE Common Stock
Tananbaum James B. - Insider Non-Derivative Transactions at KNTE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 4, 2024 | Disposition -- (Common Stock) | 520711 | 0 | 0 |
| Apr 4, 2024 | Disposition -- (Common Stock) | 9671643 | 0 | 0 |
| Apr 4, 2024 | Disposition -- (Common Stock) | 3525957 | 0 | 0 |
| May 9, 2023 | P -- (Common Stock) | 229044 | 2.8 | 520711 |
| May 9, 2023 | P -- (Common Stock) | 1550956 | 2.8 | 3525957 |
| Feb 18, 2023 | J -- (Common Stock) | 1100000 | 0 | 1975001 |